Skip to main content

ADVERTISEMENT

P. Syamasundar Rao, MD, FACC

08/29/2013
This case illustrates the risk for development of coarctation with transcatheter PDA closure, mainly with older devices such as the Gianturco-Grifka Vascular Occlude Device.
This case illustrates the risk for development of coarctation with transcatheter PDA closure, mainly with older devices such as the Gianturco-Grifka Vascular Occlude Device.
This case illustrates the risk...
08/29/2013
Journal of Invasive Cardiology
Commentary
08/01/2008
Since the description by King,1–3 Rashkind4–6 and their associates of devices to occlude atrial septal defects (ASDs), a number of ASD occluding devices have been designed, investigated and were reviewed elsewhere.7–12 The devices were...
Since the description by King,1–3 Rashkind4–6 and their associates of devices to occlude atrial septal defects (ASDs), a number of ASD occluding devices have been designed, investigated and were reviewed elsewhere.7–12 The devices were...
Since the description by...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Key words: aortic coarctation, balloon angioplasty, infants, neonates, transcatheter management Treatment of native aortic coarctation (AC) by balloon angioplasty (BA) is a controversial issue,1–6 but gradually the procedure is gaining...
Key words: aortic coarctation, balloon angioplasty, infants, neonates, transcatheter management Treatment of native aortic coarctation (AC) by balloon angioplasty (BA) is a controversial issue,1–6 but gradually the procedure is gaining...
Key words: aortic coarctation,...
08/01/2008
Journal of Invasive Cardiology
Commentary
03/31/2010
Several devices have been developed over the past four decades for transcatheter occlusion of atrial septal defects (ASD) and patent foramen ovale (PFO) starting with the first reported success in the mid-1970s by King, Mills and their...
Several devices have been developed over the past four decades for transcatheter occlusion of atrial septal defects (ASD) and patent foramen ovale (PFO) starting with the first reported success in the mid-1970s by King, Mills and their...
Several devices have been...
03/31/2010
Journal of Invasive Cardiology
Commentary
08/01/2008
Protein-losing enteropathy (PLE) may be defined as excessive loss of proteins across the intestinal mucosa and is due to either a primary gastrointestinal abnormality or secondary to cardiac disease. Initial reports of PLE secondary to...
Protein-losing enteropathy (PLE) may be defined as excessive loss of proteins across the intestinal mucosa and is due to either a primary gastrointestinal abnormality or secondary to cardiac disease. Initial reports of PLE secondary to...
Protein-losing enteropathy (PLE)...
08/01/2008
Journal of Invasive Cardiology
Commentary
12/01/2011
Since the description of successful surgical ligation of patent ductus arteriosus (PDA) by Gross and Hubbard in 1939,1 surgery has been the procedure of choice in the treatment of PDA. Surgical treatment has been shown to be safe and...
Since the description of successful surgical ligation of patent ductus arteriosus (PDA) by Gross and Hubbard in 1939,1 surgery has been the procedure of choice in the treatment of PDA. Surgical treatment has been shown to be safe and...
Since the description of...
12/01/2011
Journal of Invasive Cardiology
Commentary
08/01/2008
Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...
Patent ductus arteriosus (PDA) may be an isolated lesion or may be present in association with other defects. Isolated PDA constitutes 6–11% of all congenital heart defects. The configuration of PDA varies considerably, but most often it has...
Patent ductus arteriosus (PDA)...
08/01/2008
Journal of Invasive Cardiology
Case Report
08/01/2008
Since the initial description in late 1960s by Porstmann and associates1,2 of a patent ductus arteriosus (PDA) occluding device, a number of other devices have been studied, as reviewed elsewhere.3,4 Transcatheter closure of PDA using various...
Since the initial description in late 1960s by Porstmann and associates1,2 of a patent ductus arteriosus (PDA) occluding device, a number of other devices have been studied, as reviewed elsewhere.3,4 Transcatheter closure of PDA using various...
Since the initial description in...
08/01/2008
Journal of Invasive Cardiology
Case Report
03/30/2011
ABSTRACT: A 1.5-year-old child underwent transcatheter closure of patent ductus arteriosus (PDA) and balloon aortic valvuloplasty concurrently with excellent immediate and follow-up results. Technical details of concurrent treatment of both...
ABSTRACT: A 1.5-year-old child underwent transcatheter closure of patent ductus arteriosus (PDA) and balloon aortic valvuloplasty concurrently with excellent immediate and follow-up results. Technical details of concurrent treatment of both...
ABSTRACT: A 1.5-year-old child...
03/30/2011
Journal of Invasive Cardiology